BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35255283)

  • 1. Silibinin improves L-cell mass and function through an estrogen receptor-mediated antioxidative mechanism.
    Wang J; Zhang L; Cao H; Shi X; Zhang X; Gao Z; Ikeda K; Yan T; Jia Y; Xu F
    Phytomedicine; 2022 May; 99():154022. PubMed ID: 35255283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silychristin A activates Nrf2-HO-1/SOD2 pathway to reduce apoptosis and improve GLP-1 production through upregulation of estrogen receptor α in GLUTag cells.
    Wang J; Zhang X; Zhang L; Yan T; Wu B; Xu F; Jia Y
    Eur J Pharmacol; 2020 Aug; 881():173236. PubMed ID: 32497626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of Estrogen Receptor-α in the Activation of Nrf2-Antioxidative Signaling Pathways by Silibinin in Pancreatic β-Cells.
    Chu C; Gao X; Li X; Zhang X; Ma R; Jia Y; Li D; Wang D; Xu F
    Biomol Ther (Seoul); 2020 Mar; 28(2):163-171. PubMed ID: 31649209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk of ROS/RNS and autophagy in silibinin-induced apoptosis of MCF-7 human breast cancer cells in vitro.
    Zheng N; Liu L; Liu WW; Li F; Hayashi T; Tashiro SI; Onodera S; Ikejima T
    Acta Pharmacol Sin; 2017 Feb; 38(2):277-289. PubMed ID: 27867187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costus pictus D. Don leaf extract stimulates GLP-1 secretion from GLUTag L-cells and has cytoprotective effects in BRIN-BD11 β-cells.
    Patibandla C; Khan ZI; MacGregor L; Campbell MJ; Patterson S
    J Ethnopharmacol; 2020 Oct; 260():112970. PubMed ID: 32422353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silibinin protects rat pancreatic β-cell through up-regulation of estrogen receptors' signaling against amylin- or Aβ
    Yang J; Sun Y; Xu F; Liu W; Hayashi T; Hattori S; Ushiki-Kaku Y; Onodera S; Tashiro SI; Ikejima T
    Phytother Res; 2019 Apr; 33(4):998-1009. PubMed ID: 30729588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptors participate in silibinin-caused nuclear translocation of apoptosis-inducing factor in human breast cancer MCF-7 cells.
    Liu W; Ji Y; Sun Y; Si L; Fu J; Hayashi T; Onodera S; Ikejima T
    Arch Biochem Biophys; 2020 Aug; 689():108458. PubMed ID: 32524997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silibinin treatment protects human skin cells from UVB injury through upregulation of estrogen receptors.
    Liu W; Wang F; Li C; Otkur W; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Onodera S; Ikejima T
    J Photochem Photobiol B; 2021 Mar; 216():112147. PubMed ID: 33561689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERβ up-regulation was involved in silibinin-induced growth inhibition of human breast cancer MCF-7 cells.
    Zheng N; Liu L; Liu W; Zhang P; Huang H; Zang L; Hayashi T; Tashiro S; Onodera S; Xia M; Ikejima T
    Arch Biochem Biophys; 2016 Feb; 591():141-9. PubMed ID: 26767948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid Arthritis.
    Dupuis ML; Conti F; Maselli A; Pagano MT; Ruggieri A; Anticoli S; Fragale A; Gabriele L; Gagliardi MC; Sanchez M; Ceccarelli F; Alessandri C; Valesini G; Ortona E; Pierdominici M
    Front Immunol; 2018; 9():1903. PubMed ID: 30174672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silibinin decreases hepatic glucose production through the activation of gut-brain-liver axis in diabetic rats.
    Xu F; Yang J; Negishi H; Sun Y; Li D; Zhang X; Hayashi T; Gao M; Ikeda K; Ikejima T
    Food Funct; 2018 Sep; 9(9):4926-4935. PubMed ID: 30178798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The apoptosis and GLP-1 hyposecretion induced by LPS via RIP/ROS/mTOR pathway in GLUTag cells.
    Wang J; Wang X; Li ZZ; Guo F; Ding CZ; Zhao YY; Liu YL; Ma XJ; Li C; Wu LN; Qin Q; Zhao SY; Zhao D; Hao X; Wang SJ; Qin GJ
    Biochimie; 2019 Jul; 162():229-238. PubMed ID: 30954547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farnesoid X Receptor (FXR) Interacts with Camp Response Element Binding Protein (CREB) to Modulate Glucagon-Like Peptide-1 (7-36) Amide (GLP-1) Secretion by Intestinal L Cell.
    Li P; Zhu L; Yang X; Li W; Sun X; Yi B; Zhu S
    Cell Physiol Biochem; 2018; 47(4):1442-1452. PubMed ID: 29940597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
    Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
    Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuating effect of silibinin on palmitic acid-induced apoptosis and mitochondrial dysfunction in pancreatic β-cells is mediated by estrogen receptor alpha.
    Sun Y; Yang J; Liu W; Yao G; Xu F; Hayashi T; Onodera S; Ikejima T
    Mol Cell Biochem; 2019 Oct; 460(1-2):81-92. PubMed ID: 31183735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential molecular and cellular responses of GLP-1 secreting L-cells and pancreatic alpha cells to glucotoxicity and lipotoxicity.
    Vasu S; Moffett RC; McClenaghan NH; Flatt PR
    Exp Cell Res; 2015 Aug; 336(1):100-8. PubMed ID: 26027945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1 production in the GLUTag cell line is impaired by free fatty acids via endoplasmic reticulum stress.
    Hayashi H; Yamada R; Das SS; Sato T; Takahashi A; Hiratsuka M; Hirasawa N
    Metabolism; 2014 Jun; 63(6):800-11. PubMed ID: 24680601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silibinin induces mitochondrial NOX4-mediated endoplasmic reticulum stress response and its subsequent apoptosis.
    Kim SH; Kim KY; Yu SN; Seo YK; Chun SS; Yu HS; Ahn SC
    BMC Cancer; 2016 Jul; 16():452. PubMed ID: 27405931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chylomicrons stimulate incretin secretion in mouse and human cells.
    Psichas A; Larraufie PF; Goldspink DA; Gribble FM; Reimann F
    Diabetologia; 2017 Dec; 60(12):2475-2485. PubMed ID: 28866808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon receptor antagonist upregulates circulating GLP-1 level by promoting intestinal L-cell proliferation and GLP-1 production in type 2 diabetes.
    Lang S; Yang J; Yang K; Gu L; Cui X; Wei T; Liu J; Le Y; Wang H; Wei R; Hong T
    BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32139602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.